Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. A. van Beek

Research interests

Obesity and type 2 diabetes, particularly treatment of obesity.

HPA axis functionality and glucocorticoids.

Hormonal substitution and long-term care for pituitary patients.

Publicaties

A Western-Style Diet Influences Ingestive Behavior and Glycemic Control in a Rat Model of Roux-en-Y Gastric Bypass Surgery

Comparable results 5 years after one anastomosis gastric bypass compared to Roux-en-Y gastric bypass: a propensity-score matched analysis

DELTO Study: Delphi Consensus on Long-Term Textbook Outcome After Metabolic Bariatric Surgery

Dracaena trifasciata (Prain) Mabb leaf extract protects MIN6 pancreas-derived beta cells against the diabetic toxin streptozotocin: role of the NF-κB pathway

Fluorescence detection of pituitary neuroendocrine tumour during endoscopic transsphenoidal surgery using bevacizumab-800CW: a non-randomised, non-blinded, single centre feasibility and dose finding trial [DEPARTURE trial]

Plasma calprotectin and new-onset type 2 diabetes in the general population: a prospective cohort study

Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trial

A genome-wide association study of 24-hour urinary excretion of endocrine disrupting chemicals

Balancing Risks and Benefits: Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis

Corrigendum to “A genome-wide association study of 24-hour urinary excretion of endocrine disrupting chemicals” [Environ. Int., A Genome-Wide Association Study of 24-Hour Urinary Excretion of Endocrine Disrupting Chemicals 183 (2024) 108396]

Pers/media

Detox Holiday: Mildvasten in Portugal

Alles wat je wilt weten over diabetes

Plenadren®: enkele vragen en antwoorden

Hydrocortison

Eten voor de wetenschap

Coronapolikliniek

De dwaaltuin

Maagverkleiningen zijn booming maar denk er niet te makkelijk over.